Analysis of 4-aminobiphenyl in smoker's and nonsmoker's urine by tandem mass spectrometry

Biomarkers

Volumn 16, Issue 3, 2011, Pages 212-221

  Seyler, Tiffany H ^a   Bernert, John T ^a  

^a NATIONAL CENTER FOR ENVIRONMENTAL HEALTH   (United States)

Author keywords

Chemical carcinogenesis; mass spectroscopy; tobacco science

Indexed keywords

4 BIPHENYLAMINE; 4 BIPHENYLAMINE GLUCURONIDE; CREATININE; N ACETYL 4 BIPHENYLAMINE; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BIOLOGICAL MONITORING; CAPILLARY GAS CHROMATOGRAPHY; CREATININE URINE LEVEL; FEMALE; HUMAN; HYDROLYSIS; LIMIT OF DETECTION; MALE; SMOKING; TANDEM MASS SPECTROMETRY; URINALYSIS; URINE LEVEL;

ADULT; AMINOBIPHENYL COMPOUNDS; BIOLOGICAL MARKERS; FEMALE; HUMANS; MALE; MIDDLE AGED; SMOKING; TANDEM MASS SPECTROMETRY; YOUNG ADULT;

ANIMALIA; ESCHERICHIA COLI; HELIX POMATIA; NICOTIANA TABACUM;

EID: 79955119129     PISSN: 1354750X     EISSN: 13665804     Source Type: Journal    
DOI: 10.3109/1354750X.2010.544755     Document Type: Article

References (30)

1. Benowitz N, Jocob PI, Ahijevych K, Jarvis M, Hall S, LeHouezec J, Hansson A, Lichtenstein E, Henningfeld J, Tsoh J, Hurt R, Velicer W. (2002). Biochemical verifcation of tobacco use and cessation. Nicotine Tob Res 4:149-159. (Pubitemid 34679841)
2. Bryant MS, Skipper PL, Tannenbaum SR, Maclure M. (1987). Hemoglobin adducts of 4-aminobiphenyl in smokers and nonsmokers. Cancer Res 47:602-608. (Pubitemid 17009633)
3. Bryant MS, Vineis P Skipper PL, Tannenbaum SR. (1988). Hemoglobin adducts of aromatic amines: associations with smoking status and type of tobacco. Proc Natl Acad Sci usa 85:9788-9791. (Pubitemid 19027210)
4. Castelao JE, Yuan JM, Skipper PL, Tannenbaum SR, Gago-Dominguez M, Crowder JS, Ross RK, Yu MC. (2001). Gender-and smoking-related bladder cancer risk. j Natl Cancer Inst 93:538-545. (Pubitemid 32318433)
5. Caudill SP, Schleicher RL, Pirkle JL. (2008). Multi-rule quality control for the age-related eye disease study. Stat Med 27:4094-4106.
6. Dallinga JW, Pachen DM, Wijnhoven SW, Breedijk A, van 't Veer L, Wigbout G, van Zandwijk N, Maas LM, van Agen E, Kleinjans JC, van Schooten FJ. (1998). Te use of 4-aminobiphenyl hemoglobin adducts and aromatic DNA adducts in lymphocytes of smokers as biomarkers of exposure. Cancer Epidemiol Biomarkers Prev 7:571-577 (Pubitemid 28323883)
7. DHHS (U.S. Department of Health and Human Services). 2006. Te health consequences of involuntary exposure to tobacco smoke: a report of the Surgeon General. Atlanta: U.S. Department of Health and Human Services, CDC, National Center for Chronic Disease Prevention and Health Promotion, Ofce on Smoking and Health.
8. Fennell TR, MacNeela JP, Morris RW, Watson M, Tompson CL, Bell DA. (2000). Hemoglobin adducts from acrylonitrile and ethylene oxide in cigarette smokers: efects of glutathione S-transferase T1-null and M1-null genotypes. Cancer Epidemiol Biomarkers Prev 9:705-712. (Pubitemid 30482702)
9. Grimmer G, Dettbarn G, Seidel A, Jacob J. (2000). Detection of carcinogenic aromatic amines in the urine of non-smokers. Sci Total Environ 247:81-90. (Pubitemid 30068687)
10. Hammond SK, Coghlin J, Gann PH, Paul M, Taghizadeh K, Skipper PL, Tannenbaum SR. (1993). Relationship between environmental tobacco smoke exposure and carcinogen-hemoglobin adduct levels in nonsmokers. J Natl Cancer Inst 85:474-478. (Pubitemid 23084092)
11. IARC. (1987). IARC Monographs on the Evaluation of the Carcinogenic Risk of Chemicals to Humans.
12. Jiang X, Yuan JM, Skipper PL, Tannenbaum SR, Yu MC. (2007). Environmental tobacco smoke and bladder cancer risk in never smokers of Los Angeles County. Cancer Res 67:7540-7545. (Pubitemid 47206585)
13. Johnson HJ Jr, Cernosek SF Jr, Gutierrez-Cernosek RM, Brown LL. (1980). Development of a radioimmunoassay procedure for 4-acetamidobiphenyl, a metabolite of the chemical carcinogen 4-aminobiphenyl, in urine. J Anal Toxicol 4:86-90. (Pubitemid 10113690)
14. Ketelslegers HB, Godschalk RW, Eskens BJ, Dallinga JW, Gottschalk RW, van Schooten FJ, van Delft JH, Kleinjans JC (2009). Potential role of cytochrome P450-1B1 in the metabolic activation of 4-aminobiphenyl in humans. Mol Carcinog 48:685-691.
15. Mendes P Liang Q, Frost-Pineda K, Munjal S, Walk RA, Roethig HJ. (2009). Te relationship between smoking machine derived tar yields and biomarkers of exposure in adult cigarette smokers in the US. Regul Toxicol Pharmacol 55:17-27.
16. Richter E, Branner B. (2002). Biomonitoring of exposure to aromatic amines: haemoglobin adducts in humans. J Chromatogr B Analyt Technol Biomed Life Sci 778:49-62.
17. Riedel K, Scherer G, Engl J, Hagedorn HW, Tricker AR. (2006). Determination of three carcinogenic aromatic amines in urine of smokers and nonsmokers. J Anal Toxicol 30:187-195. (Pubitemid 44285276)
18. Rifelmann M, Müller G, Schmieding W, Popp W, Norpoth K. (1995). Biomonitoring of urinary aromatic amines and arylamine hemoglobin adducts in exposed workers and nonexposed control persons. Int Arch Occup Environ Health 68:36-43. (Pubitemid 26003005)
19. Sarkar M, Liu J, Koval T, Wang J, Feng S, Serafn R, Jin Y Xie Y Newland K, Roethig HJ. (2010). Evaluation of biomarkers of exposure in adult cigarette smokers using Marlboro snus. Nicotine Tob Res 12:105-116.
20. Schnell FC. (1994). Reviews in Environmental Toxicolgoy. Vol. 5. ed. Hodgson E. Toxicology Communications, Inc.: Raleigh, NC:51-160.
21. Seyler TH, Reyes LR, Bernert JT. (2010). Analysis of 4-aminobiphenyl hemoglobin adducts in smokers and nonsmokers by pseudo capillary on-column gas chromatography-tandem mass spectrometry. J Anal Toxicol 34:304-311.
22. Silverman DT, Hartge P, Morrison AS, Devesa SS. (1992). Epidemiology of bladder cancer. Hematol Oncol Clin North Am 6: 1-30.
23. Skipper PL, Tannenbaum SR. (1994). Molecular dosimetry of aromatic amines in human populations. Environ Health Perspect 102 Suppl 6:17-21. (Pubitemid 24364872)
24. Skipper PL, Tannenbaum SR, Ross RK, Yu MC. (2003). Nonsmoking-related arylamine exposure and bladder cancer risk. Cancer Epidemiol Biomarkers Prev 12:503-507. (Pubitemid 36713643)
25. Stillwell WG, Bryant MS, Wishnok JS. (1987). GC/MS analysis of biologically important aromatic amines. Application to human dosimetry. Biomed Environ Mass Spectrom 14:221-227. (Pubitemid 17093966)
26. Talaska G, Al-Zoughool M. (2003). Aromatic amines and biomarkers of human exposure. J Environ Sci Health c Environ Carcinog Ecotoxicol Rev 21:133-164. (Pubitemid 37466163)
27. Teass AW, DeBord DG, Brown KK, Cheever KL, Stettler LE, Savage RE, Weigel WW, Dankovic D, Ward E. (1993). Biological monitoring for occupational exposures to o-toluidine and aniline. Int Arch Occup Environ Health 65:S115-S118. (Pubitemid 23303162)
28. Vineis P. (1994). Epidemiology of cancer from exposure to arylamines. Environ Health Perspect 102 Suppl 6:7-10. (Pubitemid 24364870)
29. Yu MC, Skipper PL, Taghizadeh K, Tannenbaum SR, Chan KK, Henderson BE, Ross RK. (1994). Acetylator phenotype, aminobiphenyl-hemoglobin adduct levels, and bladder cancer risk in white, black, and Asian men in Los Angeles, California. J Natl Cancer Inst 86:712-716. (Pubitemid 24138978)
30. Zenser TV, Lakshmi VM, Davis BB. (1999). Human and Escherichia coli beta-glucuronidase hydrolysis of glucuronide conjugates of benzidine and 4-aminobiphenyl, and their hydroxy metabolites. Drug Metab Dispos 27:1064-1067. (Pubitemid 29409643)